Your browser is out-of-date!

Update your browser to view this website correctly. Update my browser now


Syntax-Brillian Remains On Nasdaq

Tempe, Ariz. — Despite a delay in the filing of Syntax-Brillian’s 10-Q quarterly report for the period ended Dec. 31, the Nasdaq Listing Qualifications Panel has granted the company’s request to continue its listing on the Nasdaq stock exchange, Syntax-Brillian said Thursday.

In addition to addressing other items pertaining to the audit committee, the panel’s decision requires the company to file the December 10-Q form by July 31, 2008.

During this period, the securities of Syntax-Brillian will remain listed on The Nasdaq Global Market, the company said.

“In addition to the Nasdaq matter, we are also focusing on the continuity of our business and continue to fulfill orders from retailers for our Olevia and Vivitar products in preparation for their Fourth of July and back-to-school promotions,” stated James Li, Syntax-Brillian president and CEO. “We anticipate continued demand as we plan the launch of new Olevia and Vivitar products, which are currently in our development pipeline for availability later this year.”